Providing Clarity of Fetus Heartbeat Through Baby Beat Bracelet Measuring Fetal Arterial Pulse Wave

Projektinformationen

Baby Beat

ID Finanzhilfevereinbarung: 673011

DOI 10.3030/673011

Das Projekt endete am 14 Januar 2017

EK-Unterschriftsdatum 7 Juli 2015

Startdatum 1 Mai 2015

Enddatum 30 April 2017

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Gesamtkosten € 1 091 515,00

EU-Beitrag € 764 060,00

Koordiniert durch

BCB Informatica y Control S.L.
Spain

Ziel

Baby Beat represents our innovative response to the declining birthrate, increasing pregnancy risks and risks related to the generally higher age of pregnant women. It consists of a bracelet with integrated non-invasive technology that continuously measures the fetal heartbeat 24 hours, 7 days a week from around Week 20 of the pregnancy. This wearable device communicates with smart phones via Bluetooth and generates automatic alarms when the fetal heartbeat exceeds specific thresholds. The main innovations are that this method is non-invasive unlike all other devices available on the market and that it will be available at an attainable price of a few hundred euros. The overall objective of Phase II is to miniaturize the existing prototype, to test and demonstrate its usefulness on a larger group of pregnant women in clinical trials, and to obtain the necessary certifications for Baby Beat to become a medical device.
The market size for Baby Beat is promising when considering the number of pregnancies per year, following the trends of the prenatal retail market and considering the boom of non-invasive prenatal tests. There are 23 million pregnancies in the developed world itself. We will follow a two-tiered business model with direct sales through pharmacies and indirect sales through insurance companies, hospitals and clinics. This will allow us to boost our company growth and to create a significant amount of new jobs.
With our medical device and software, we foster the prevention of prenatal problems, and facilitate the provision of personalized care: high risk cases do not remain undiscovered, risk patients only proceed with visits if Baby Beat indicates a need, risk patients do not need to be hospitalized and different agents of the healthcare system will better coordinated.

Wissenschaftliches Gebiet

• natural sciences › computer and information sciences › software
• engineering and technology › electrical engineering, electronic engineering, information engineering › information engineering › telecommunications › radio technology › bluetooth
• medical and health sciences › clinical medicine › obstetrics
• medical and health sciences › clinical medicine › embryology
• medical and health sciences › basic medicine › pharmacology and pharmacy

Schlüsselbegriffe

• Non-invasive prenatal diagnostics
• fetal heart rate monitoring
• prenatal medical device
• wearable device
• Self-mixing interferometry
• algorithms
• smartphone
• android
• iOS
• wireless communications

Programm/Programme

• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• ICT-37-2014 - Open Disruptive Innovation Scheme (implemented through the SME instrument)

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2014-2015

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-2-2014

Finanzierungsplan

SME-2 - SME instrument phase 2

Koordinator

BCB Informatica y Control S.L.

• Netto-EU-Beitrag: € 764 060,00
• Adresse: Calle Fernando el Catolico 11/2B DCHA ; 28015 Madrid ; Spanien
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Comunidad de Madrid › Comunidad de Madrid › Madrid
• Region: Comunidad de Madrid › Comunidad de Madrid › Madrid
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 1 091 515,00